# AMLODIPINE BESYLATE

NDC: 51655-044
Generic name: AMLODIPINE BESYLATE
Labeler / Manufacturer: Northwind Health Company, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20231130

FDA application: ANDA077073

## Active ingredients

- AMLODIPINE BESYLATE: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51655-044"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51655-044
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0c5784b9-5542-144f-e063-6394a90a7ebc